Venipuncture: Clinical Trials

4 trials of Venipuncture, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Withdrawn 1
Phase 12Completed 2

Follow Venipuncture: new trials by email Literature Review of Venipuncture trials Research Report on Venipuncture

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Polyclonal Regulatory T Cells, Everolimus, Tacrolimus - Kidney Transplant, Adult Living Donor Kidney Transplant Recipients
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)322016-09-202026-09-24
Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy
Cabazitaxel, Neulasta, CT Scan - Urothelial Carcinoma
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University142012-02-162025-05-04
A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia
VEGF Trap, Bone marrow biopsy, bone marrow aspiration - Leukemia
Phase 2WithdrawnVanderbilt-Ingram Cancer Center2007-03-012013-04-02
Phase I/II Thymus Transplantation With Immunosuppression #950
Cultured Thymus Tissue for Implantation (CTTI), Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation, Blood Draw - DiGeorge Anomaly, Complete DiGeorge Anomaly
Phase 1 / Phase 2CompletedSumitomo Pharma Switzerland GmbH142005-12-192022-03-25

Conditions studied

Carcinoma, Transitional Cell (1)  ·  DiGeorge Syndrome (1)  ·  Hypocalcemia (1)  ·  Hypoparathyroidism (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Thymic aplasia (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  Sumitomo Pharma Switzerland GmbH (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

United States (3)

Top investigators

Flavio Vincenti, MD (1)  ·  Jean Hoffman-Censits, MD (1)  ·  M. Louise Markert, MD, PhD (1)  ·  Sindhu Chandran, MD (1)  ·  Stephen Strickland, MD (1)

Results publications

PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 23607606

NIH funding

K12HD043494 (1), P30CA068485 (1), R01AI047040 (1), R01AI054843 (1)